CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported the grant of an inducement award to its new Chief Executive Officer, Paris Panayiotopoulos. The award was approved by the Compensation Committee and ratified by the full Board of Directors on December 16, 2015, as an inducement material to Mr. Panayiotopoulos’ entering into employment with the Company in accordance with NASDAQ Listing Rule 5635(c)(4). The award was approved subject to Mr. Panayiotopoulos’ commencement of employment with the Company on January 4, 2016, and in consultation with and upon the advice and recommendation of the Compensation Committee’s independent compensation consultant.
